Leerink Partnrs Issues Negative Outlook for VKTX Earnings
Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Stock analysts at Leerink Partnrs cut their Q2 2025 earnings estimates for shares of Viking Therapeutics in a research note issued to investors on Wednesday, April 23rd. Leerink Partnrs analyst T. Smith now expects that the biotechnology company will post earnings per share of ($0.44) for the […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Stock analysts at Leerink Partnrs cut their Q2 2025 earnings estimates for shares of Viking Therapeutics in a research note issued to investors on Wednesday, April 23rd. Leerink Partnrs analyst T. Smith now expects that the biotechnology company will post earnings per share of ($0.44) for the […]
